How Much Upside is Left in Intellia Therapeutics (NTLA)? Wall Street Analysts Think 398.31%

Shares of Intellia Therapeutics, Inc. (NTLA) have gained 6.1% over the past four weeks to close the last trading session at $7.69, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$38.32 indicates a potential upside of 398.3%.The average comprises 25 short-term price targets ranging from a low of $7 to a high of$106, with a standard deviation of $24.94. While the lowest estimate ...